Journal Updates
eMediNexus Coverage from: 
Ivermectin + diethylcarbamazine + albendazole clears microfilaremia in lymphatic filariasis
eMediNexus,  11 November 2018
remove_red_eye 683 Views
#Dermatology #Hospital Medicine #Infectious Diseases

3 Read Comments                

In a randomized, controlled trial involving adults from Papua New Guinea with Wuchereria bancrofti microfilaremia, the three-drug regimen of ivermectin + diethylcarbamazine + albendazole induced clearance of microfilariae from the blood for 3 years in almost all participants who received the treatment and was superior to the two-drug regimen of diethylcarbamazine + albendazole administered once and noninferior to the two-drug regimen administered once a year for 3 years. These findings are published in the New England Journal of Me
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!